PIERIS PHARMACEUTICALS, INC. (PIRS) Depreciation USD 2013 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Pieris Pharmaceuticals, Inc. annual/quarterly Depreciation history and growth rate from 2013 to 2023.
  • Pieris Pharmaceuticals, Inc. Depreciation for the quarter ending March 31, 2020 was $339 K, a 104% increase year-over-year.
  • Pieris Pharmaceuticals, Inc. annual Depreciation for 2023 was $1.8 M, a 21.7% decline from 2022.
  • Pieris Pharmaceuticals, Inc. annual Depreciation for 2022 was $2.3 M, a 4.17% decline from 2021.
  • Pieris Pharmaceuticals, Inc. annual Depreciation for 2021 was $2.4 M, a 14.3% increase from 2020.
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.8 M -$500 K -21.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-29
2022 $2.3 M -$100 K -4.17% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-29
2021 $2.4 M +$300 K +14.3% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 $2.1 M +$1.5 M +250% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-02
2019 $600 K +$30 K +5.26% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-31
2018 $570 K +$201 K +54.5% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-13
2017 $369 K +$8 K +2.22% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-18
2016 $361 K +$53.1 K +17.2% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-15
2015 $308 K -$59.1 K -16.1% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-30
2014 $367 K -$17.7 K -4.6% Jan 1, 2014 Dec 31, 2014 10-K 2016-03-23
2013 $385 K Jan 1, 2013 Dec 31, 2013 10-K 2015-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.